Publication | Open Access

Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells

Combinatorial ChemistryMedicinal ChemistryThymidylate Synthase InhibitorsNatural SciencesMedicineDiversity-oriented SynthesisBreast Cancer CellsAnti-cancer AgentClick ChemistryPharmacologyRadiation Oncology1,2,3-Triazole HybridsDrug Discovery